Clinical trial
A Study of Supaglutide in Chinese Type 2 Diabetes Patients
NCT04314622
Study timeline
Study start (actual)2020-04-14Date precision: day
Registry last updated2021-09-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
SupaglutideDRUG
PlaceboDRUG
Sponsors & collaborators
Shanghai 6th People's Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04314622 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.